Guardian Pharmacy Services, Inc. (GRDN) stock

GRDNNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/30160% above fair value

$49.38−0.60 (-1.20%)

Close on Nov 12, 2026Market cap $3.13BP/E –Yield –

Guardian Pharmacy Services r&d expenses

Research and development expenses are spending on new products and technology.

Guardian Pharmacy Services has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in Guardian Pharmacy Services's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is GRDN.

Revenue growth4.9% · median -0.0%

Gross margin22.4% · median 33.7%

Operating margin6.5% · median -5.7%

Net margin5.1% · median -6.7%

Advertisement
300 × 250

See a number that looks wrong?